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Abstract IgE is the least abundant circulating antibody class but is constitutively present in
healthy tissues bound to resident cells via its high-affinity receptor, FceRI. The physiological role of
endogenous IgE antibodies is unclear but it has been suggested that they provide host protection
against a variety of noxious environmental substances and parasitic infections at epithelial barrier
surfaces. Here we show, in mice, that skin inflammation enhances levels of IgE antibodies that have
natural specificities and a repertoire, VDJ rearrangements and CDRH3 characteristics similar to
those of IgE antibodies in healthy tissue. IgE-bearing basophils are recruited to inflamed skin via
CXCL12 and thymic stromal lymphopoietin (TSLP)/IL-3-dependent upregulation of CXCR4. In the
inflamed skin, IgE/FceRI-signalling in basophils promotes epithelial cell growth and differentiation,
partly through histamine engagement of H1R and H4R. Furthermore, this IgE response strongly
drives tumour outgrowth of epithelial cells harbouring oncogenic mutation. These findings indicate
that natural IgE antibodies support skin barrier defences, but that during chronic tissue
inflammation this role may be subverted to promote tumour growth.
Introduction
IgE is present at low concentrations in the blood and is the least abundant circulating antibody class.
However, all epithelial tissues contain resident cells constitutively binding IgE antibodies. Although
the half-life of free IgE in the serum is short (1–2 days), tissue-resident IgE may persists for weeks or
months (Geha et al., 2003). In the tissue, IgE is bound with high affinity to its receptor, FceRI, and
can remain bound for the life of the FceRI-bearing cell (MacGlashan, 2008). The specificity and func-
tion of this endogenous IgE in healthy individuals is unclear, although spontaneous production of
natural IgE has been suggested to be a component of innate tissue defence (McCoy et al., 2006;
Palm et al., 2012).
Mast cells and basophils are the only two cell types that express the complete high-affinity recep-
tor for IgE (FceRI) with all four polypeptide subunits (abg2). In humans, subsets of dendritic cells,
monocytes and eosinophils can express low levels of FceRI but only as a trimer, lacking the b chain
(ag2). The density of mast cell and basophil FceR1 expression correlates with serum IgE levels, so an
increase in IgE antibody may directly increase FceRI signalling (Lawrence et al., 2017). Mast cells
and basophils are potent innate effector cells that have overlapping effector functions. Paul Ehrlich
first described mast cells and basophils in 1878, and estimated that there were enough mast cells in
the body to make up ‘an organ the size of the spleen’ (Crivellato et al., 2003). Mast cells are consti-
tutively resident in tissues, such as the skin, whereas basophils are circulating cells that rapidly
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infiltrate inflamed tissues. Crosslinking of FceRI-bound IgE on these cells causes degranulation and
immediate release of potent pharmacologically active pre-formed mediators and concurrent synthe-
sis of cytokines/chemokines and inflammatory lipid mediators. Although the in vivo role(s) of both
cell types is only partially understood, it has been suggested that they mediate a ‘gate-keeper’ func-
tion and promote barrier defences at the skin and mucosal surfaces (Voehringer, 2013).
IgE antibodies have been studied most commonly in the context of atopic allergic diseases or
parasitic infections. However, it has been proposed that they also play an important protective role
in host defence against noxious environmental substances such as venoms, hematophagous fluids,
environmental xenobiotics and irritants (Palm et al., 2012; Profet, 1991). In support of this, we
recently demonstrated that topical exposure to environmental carcinogens promotes potent de
novo induction of autoreactive IgE antibodies, and that these IgE antibodies provide protection
against epithelial carcinogenesis in the exposed tissue (Crawford et al., 2018). The induction of IgE
was dependent on epithelial cell (EC) DNA-damage, and deep-sequencing of these IgE antibodies
revealed that they have a unique repertoire with specific VDJ rearrangements and CDRH3
characteristics that are distinct from those of IgE produced during general tissue inflammation
(Crawford et al., 2018).
Epidermal hyperplasia and inflammation are hallmarks of a wide range of skin conditions. Further-
more, chronic inflammation may aid the proliferation and survival of EC harbouring genomic altera-
tions, and so is now widely accepted to promote cancer development (Mantovani et al., 2008;
Coussens et al., 2013; Grivennikov et al., 2010). Here, we explored the nature of inflammation-
induced IgE antibodies and their role in tissue homeostasis. We show that general tissue inflamma-
tion enhances the levels of polyclonal natural IgE with similar characteristics and VDJ usage as IgE in
naı¨ve animals. Furthermore, this IgE, via FceRI-signalling in basophils, potently promotes epidermal
hyperplasia and inflammation-driven outgrowth of skin tumours following subclinical carcinogen
exposure. Tissue inflammation recruits IgE-bearing basophils to the skin via CXCL12 and TSLP/IL-3-
dependent upregulation of CXCR4 on circulating basophils. IgE-dependent basophil degranulation
in the skin supports EC proliferation and differentiation, partly via histamine. Overall, our studies
demonstrate how endogenous IgE antibodies that have natural specificities potently affect skin EC
growth and differentiation with implications for both atopy and cancer.
Results
Skin inflammation increases IgE levels locally and systemically
Both basophils and mast cells carry a high number of FceRI receptors, which are usually occupied
with IgE (Lawrence et al., 2017). Consistent with this, a horizontal view of resting healthy murine
skin revealed that large amounts of IgE was normally present in the tissue (Figure 1a) despite very
low levels in serum (Figure 1b–d). IgE in resting skin was mainly found on cells around the hair-fol-
licles (Figure 1a). Topical exposure to agents that induce skin inflammation, such as 12-O-tetradeca-
noylphorbol-13-acetate (TPA, a protein kinase C activator) (Figure 1b), MC903 (a vitamin D3
analogue commonly used to induce atopic dermatitis-like inflammation) (Figure 1c) and R848 (resi-
quimod, a toll-like receptor seven agonist commonly used to induce psoriasis-like inflammation)
(Figure 1d), significantly enhanced the circulating levels of IgE compared to those in untreated or
vehicle-treated animals. Enhancement of serum IgE was dependent on topical exposure: intravenous
(i.v.) or intraperitoneal (i.p.) administration did not trigger the same effect, as shown by R848 expo-
sure (Figure 1d).
The increase in serum IgE was accompanied by an increase in the number of IgE-secreting plasma
cells in the skin-draining lymph nodes (LNs) (Figure 1e,f). IgE levels were also increased locally in the
skin following topical TPA treatment (Figure 1g), but most notably the cells carrying the IgE
switched from being predominantly mast cells in resting untreated skin to mainly basophils in TPA-
treated inflamed skin (Figure 1h,i). 24 hr after cessation of TPA treatment, only a few mast cells
remained in the skin, while IgE-bearing basophils accounted for ~2% of total CD45+ leukocytes.
Basophil numbers further increased at 48 hr after cessation of TPA treatment and then declined as
the inflammation subsided, while mast cells returned to the skin (Figure 1i). Thus, untreated resting
skin contains high levels of IgE antibodies that are predominately carried on mast cells. Skin
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Figure 1. Skin inflammation increases IgE levels locally and systemically. (a) Representative image of IgE staining (red) in healthy dermal skin.
Scale = 50 mm. The image is representative of tile-scans from healthy untreated (UT) dermal sheets of five independent mice. (b–d) ELISA of IgE in
serum of UT wildtype (WT) BALB/c mice and mice treated on the dorsal ear skin with (b) 2.5 nM TPA 2x a week for 2 weeks or vehicle control (ethanol)
(n = 8), (c) 1 nM MC903 5x a week for 2 weeks or vehicle control (ethanol) (n = 5) or (d) 100 mg R848 3x a week for 2 weeks or similarly i.v. or i.p. (n = 4).
Figure 1 continued on next page
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inflammation increases IgE levels locally and systemically, and IgE antibodies in inflamed skin are
mainly carried on basophils.
Skin inflammation enhances polyclonal ‘natural IgE’ with characteristics
similar to those in naı¨ve animals
To understand the nature of IgE-induced during skin inflammation, we performed high-throughput
sequencing of the IgE heavy-chain repertoire from mice exposed topically to TPA. This revealed the
repertoires to be highly diverse and polyclonal with ~75% of the repertoire consisting of clone
sizes  10 (Figure 2a), which was similar to that seen in untreated naı¨ve mice. This suggests that no
notable selection or clonal expansion had occurred. The most prominent effects of B cell selection
can be seen in heavy-chain gene-usage and in CDRH3 characteristics. Thus, we analysed the use of
genes encoding the variable, diversity and joining (VDJ) regions of the IgE heavy-chain and found
that IgHV1 was the most dominant Igh-V family gene, accounting for >70% of the repertoire
(Figure 2b). All four Igh-J family genes and six Igh-D family genes were used, although IgHD2 domi-
nated (Figure 2c). The overall VDJ family gene usage in untreated naı¨ve mice and in the TPA-treated
mice was similar (Figure 2b,c). Further, we analysed the characteristics and physicochemical proper-
ties of the complementarity-determining CDRH3 regions because these form an important part of
the antigen-binding site of the antibody. We found no differences in CDRH3 length, levels of muta-
tion, aliphatic index or isoelectric point (pI) between the IgE sequenced from TPA-treated or
untreated mice (Figure 2d), suggesting that the TPA-induced skin inflammation did not alter the
composition or the nature of the IgE response. The dominant use of the V1 family and the low muta-
tion rate are consistent with those of ‘natural IgE’ (McCoy et al., 2006), thus we next tested whether
the inflammation-induced IgE repertoire contained the characteristic natural anti-phosphorylcholine
(anti-PC) (Kearney, 2005) specificity. This analysis showed that skin inflammation enhanced
the production of anti-PC IgE to a level similar to that of the spontaneous production of natural IgE
seen in immunodeficient Tcrb–/– mice (Figure 2e). Levels of circulating anti-PC IgE increased further
in skin-tumour-bearing mice that had been exposed to TPA for 20 weeks (Figure 2e). Together, this
analysis revealed that skin inflammation enhances levels of undiversified natural IgE akin to the IgE
spontaneously present at low levels in healthy mice.
IgE promotes inflammation-driven outgrowth of skin tumours
We have recently reported that IgE antibodies that are induced de novo following repeated topical
exposure to environmental carcinogens is protective in a mutation-driven cutaneous carcinogenesis
model, and that the repertoire of the carcinogen-induced IgE differed substantially from the IgE
induced by general skin inflammation (Crawford et al., 2018). We therefore tested whether natural
IgE would influence cutaneous carcinogenesis in an inflammation (TPA)-driven model. This
question was explored in a widely used two-stage model, in which topical exposure to a subclinal
dose of the carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) provokes few oncogenic mutations
in EC (not enough for cancer growth) that can subsequently be promoted to grow into overt
tumours by chronic tissue inflammation (Abel et al., 2009). Mice lacking IgE (Igh7–/–) were markedly
protected from developing tumours in this two-stage model (Figure 3a). Although Igh7–/– mice
showed an equivalent level of DNA-damage to WT following carcinogen exposure (Figure 3—figure
supplement 1a), as assessed by staining for the phosphorylated histone H2A variant H2AX (gH2AX),
only a few Igh7–/– mice developed tumours and the ones that did grew only very few and
Figure 1 continued
Data are expressed as means ± SEM. (e, f) Fluorescence-assisted cell sorting (FACS) analysis of IgE-secreting plasma cells in the skin draining LNs of UT
WT mice and mice exposed topically to TPA on the dorsal side of the ears 2x a week for 2 weeks. (e) Representative plots of plasma cells gated as
FSChiCD95+CD138+ cells, and with intracellular IgE staining to show isotype switching. (f) Enumeration of IgE+ plasma cells in skin draining LN (n = 4).
(g) Representative images of IgE staining (green) in UT and TPA treated whole skin. Nuclei in blue. Scale = 100 mm. Images are representative of tile-
scans from ear cross-sections from six independent mice. (h, i) FACS analysis of IgE-bearing cells in whole naı¨ve UT skin and in TPA-treated skin (TPA 2x
a week for 2 weeks). (h) Representative plots of IgE-bearing mast cells (green) and basophils (blue) 48 hr after last TPA exposure. (i) Enumeration of IgE-
bearing mast cells and basophils at the indicated time points after topical TPA. Mast cells were defined as CD45hicKit+IgE+CD41– and basophils as
CD45locKit–IgE+CD41+(n = 5). One-way ANOVA multiple comparison (b, d) and two-tailed Student’s t-test for unpaired data (c, f) were used to test for
statistical difference. **p<0.01 and ****p<0.0001. IP, intraperitoneal; IV, intravenous; UT, untreated.
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Figure 2. Skin inflammation induces polyclonal ‘natural IgE’ antibodies with characteristics similar to those of IgE antibodies in naı¨ve animals. (a–d)
High-throughput sequencing and heavy-chain repertoire analysis of IgE in sorted FSChiCD95hiCD138+ plasma cells from skin-draining LNs of
wildtype (WT) mice 7 days after topical exposures to TPA (TPA 2x a week for 2 weeks) (n = 6) and in whole spleen from untreated (UT) naı¨ve mice
(n = 5). (a) % of the total repertoire consisting of clone sizes  10. (b) Igh-V gene family usage expressed as mean of total repertoire ± SEM. V genes
Figure 2 continued on next page
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significantly smaller papillomas (Figure 3a), suggesting that the lack of IgE during TPA promotion
hindered tumour growth. The topical TPA application enhanced the circulating levels of IgE in WT
animals throughout the experiment (Figure 3b). Igh7–/– mice developed no IgE and reduced levels
of IgG1 and IgG2a compared to WT animals (Figure 3—figure supplement 1b). Analysis of the
tumour tissue and the peri-lesional skin by flow cytometry (Figure 3c) and by qRT-PCR (Figure 3d)
showed that basophils were the predominant cells carrying IgE in the tumours with very few mast
cells entering the tumour. The peri-lesional skin contained both mast cells and basophils, whereas
mast cells dominated in untreated belly skin from the same animals (Figure 3c,d). Cross-sections of
whole tumours showed that IgE-bearing cells accumulated right up to the tumour, mainly in the peri-
tumoural infiltrate (Figure 3e), with some also entering the epithelium (Figure 3e inset). Thus, TPA-
enhanced accumulation of IgE-bearing cells potently promotes the outgrowth of inflammation-driven
tumours, with IgE-bearing basophils accumulating inside skin tumours.
IgE exacerbates skin inflammation by altering the microenvironment
and inducing epithelial hyperplasia
To further explore the role of IgE antibodies during TPA-induced inflammation (the tumour promo-
tion phase), we investigated the skin microenvironment following repeated topical application
of TPA on its own to the ear skin. This showed that TPA caused substantial de novo infiltration of
CD45+ leukocytes into the skin, which was equal in WT and Igh7–/– mice (Figure 4a). There were no
substantial differences in the cellular composition of the infiltrates, aside from a minor increase in
dermal Vg5– gd T cells, and importantly no difference in mast cell or basophil numbers in
either untreated or TPA-treated skin (Figure 4a and Figure 4—figure supplement 1a). Similar
results were found in TPA-treated Fcer1a–/– mice (Figure 4—figure supplement 1b). Nevertheless,
qRT-PCR analysis of whole skin during TPA-induced inflammation showed that IgE-deficient mice
had significantly lower levels of IL-4, IL-5, IL-6 and IL-33 but produced similar levels of TNFa and
higher levels of IL-25 transcripts (Figure 4b). In addition, FceRI+ cells isolated from inflamed skin
spontaneously produced some IL-4 and IL-13 protein, and this was further increased by IgE crosslink-
ing (Figure 4—figure supplement 2a,b). A low amount of IL-5 protein was also detected (Figure 4—
figure supplement 2a,b). Furthermore, IgE-deficient animals showed no enhancement of the
enzyme histidine decarboxylase (HDC) responsible for generating histamine and significantly lower
levels of the enzymes involved in the production of bioactive prostanoids such as PGD2 and PGE2
compared to WT mice (Figure 4b). Consistent with this, a significant amount of histamine was found
to be released in the inflamed skin (Figure 4c) and into the serum (Figure 4d) of TPA-treated WT
mice but not of TPA-treated Igh7–/– mice (Figure 4c,d), suggesting that degranulation and histamine
discharge was dependent on IgE engagement. Skin analysis by immunohistochemistry also showed
obvious changes in TPA-treated inflamed skin in the absence of IgE antibodies. Although both WT
and Igh7–/– mice showed a large and equal immune infiltrate in the dermis (Figure 4a,e), significantly
less epithelial hyperplasia was detected in the absence of IgE (Figure 4e,f). Together these data
demonstrate that the lack of IgE substantially alters the skin microenvironment and decreases inflam-
mation-associated epithelial hyperplasia.
IgE activity in inflamed skin is mediated by FceRI-signalling in basophils
To determine which cells were primarily responsible for the IgE-mediated exacerbation of skin
inflammation, we sorted IgE-bearing mast cells and basophils from TPA-treated skin at a time-point
when both cell populations were present. This showed that basophils produced vast amounts of
cytokines such as IL-4, IL-6 and IL-13, and that they were significantly more immune active than mast
cells from the same tissue (Figure 5a and Figure 5—figure supplement 1). Basophils sorted from
Figure 2 continued
that are not used in the repertoire of any mouse are not included for clarity. (b) Paired DJ repertoire shown as average Igh-D and Igh-J use of total
repertoire in UT (left) and TPA-treated (right) mice. (d) Physicochemical properties of the CDRH3 regions; length (number of amino acids), % mutation
compared to germline, aliphatic index and isoelectric point (pI) presented as mean ± SEM. (e) Level of IgE in serum specific for phosphorylcholine (PC)
in UT WT (n = 6), UT Tcrb–/– (n = 5), 10x TPA-treated (2x/week) WT mice (n = 6) and in WT mice that have undergone 7,12-dimethylbenz[a]
anthracene (DMBA)-TPA carcinogenesis (single low-dose DMBA + 20 weeks TPA, 2x/week) (n = 14). Data are presented as means ± SEM. Statistics by
two-tailed Student’s t-test for unpaired data (a, b, d) and one-way ANOVA multiple comparison (e); *p<0.05 and ****p<0.0001.
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ns = not significant.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. IgE-deficient mice acquire DNA-damage when exposed to DMBA but develop fewer antibodies during DMBA-TPA
carcinogenesis.
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Figure 4. IgE alters the inflamed skin microenvironment and induces epithelial hyperplasia. (a–f) Analysis of the skin microenvironment in untreated (UT)
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the spleen of the same animal did not express cytokine transcripts (Figure 5b), suggesting that the
basophils only became activated when entering the inflamed skin. IgE was partly required to activate
the basophils for cytokine production when entering the skin (Figure 5a and Figure 5—figure sup-
plement 1), and IgE-signalling was necessary for degranulation and histamine release because hista-
mine was absent from the skin and serum of both Fcer1a–/– mice (Figure 5c) and Igh7–/– mice
(Figure 4c,d). Indeed, mice with a constitutive depletion of basophils resulting from Cre toxicity
(Ohnmacht et al., 2010) (Mcpt8Cre/+) showed a very limited release of histamine in inflamed skin
and an absence of histamine in the serum (Figure 5c). These mice also demonstrated significantly
less TPA-induced epithelial hyperplasia compared to WT mice (Figure 5d).
To investigate how IgE-mediated activation of basophils may affect skin EC, neonatal skin EC
(keratinocytes) were grown in vitro and at 70% confluency supplemented with media from IgE-acti-
vated basophils or media alone as control. Basophil-derived conditioned media induced significant
upregulation of Ki67 in EC, downregulation of the basal keratins K5 and K14, and upregulation of
the suprabasal keratins K1 and K10 (Figure 5e), suggesting that basophil-released mediators pro-
moted proliferation and upwards differentiation of skin EC. Basophil media also induced the expres-
sion of inflammatory cytokines such as IL-1a, IL-18 and IL-31 in EC (Figure 5—figure supplement 2).
A similar pattern of induced expression of Ki67 and suprabasal keratin K1 and reduced expression of
K14 was demonstrated when EC were grown in vitro with histamine (Figure 5f), and the dose-
dependent response to histamine was completely blocked when the EC cultures were pre-incubated
with histamine receptor 1 or 4 (H1R or H4R) antagonists (Figure 5f). Indeed, the basophil-induced
EC proliferation and differentiation was also partially impeded by H1R or H4R blockade both in vitro
(Figure 5g) and in vivo (Figure 5h). Thus, IgE-signalling in skin-infiltrating basophils directly promote
EC activation, proliferation and differentiation, partly via the activities of histamine receptors H1R
and/or H4R on EC.
Basophil recruitment to the skin is dependent on TSLP/IL-3-mediated
upregulation of CXCR4
Next, we explored how IgE-bearing basophils are recruited to inflamed skin. Treating mice with per-
tussis toxin (PTX) prior to topical TPA significantly reduced the recruitment of basophils to the skin
(Figure 6a), indicating a role for G-protein-coupled receptors such as chemokine receptors (CCRs) in
this process. In support of this idea, TPA-treated inflamed skin showed increased levels of Ccl2,
Ccl5, Ccl8, Ccl11 and Cxcl12 mRNAs when compared with normal UT skin (Figure 6b). In parallel,
infiltrating basophils showed preferential expression of Cxcr2, Cxcr4 and Ptger2 (CrTH2 – the PGD2
receptor), which differed significantly from the CCRs expressed on mast cells from the same tissue
(Figure 6c). Therefore, we tested the effect of blocking the most abundant chemokine receptors on
basophil recruitment to inflamed skin. Blocking CXCR2 with a neutralising antibody inhibited the
TPA-induced recruitment of neutrophils but not of basophils (Figure 6d), whereas mice lacking
CCR2 (Ccr2–/–) had reduced recruitment of monocytes but not of basophils (Figure 6e). Inhibition of
CrTH2-signalling by COX-2 blockade or by injection of a small molecule inhibitor (AMG 853) had no
effect on the recruitment of any cell type to the inflamed skin (data not shown). By contrast, blocking
CXCR4 with a neutralising antibody significantly and selectively reduced basophil infiltration to the
inflamed skin (Figure 6f), suggesting a role for CXCL12-CXCR4 in driving the basophil recruitment.
However, although resting basophils abundantly expressed CXCR4, most of this was intracellular
(Figure 6g); therefore, we explored whether any mediators that are released during skin inflamma-
tion might upregulate the surface expression of CXCR4 by basophils. Indeed, basophils
Figure 4 continued
cyclophilin (n = 5). (c, d) ELISA assessing the amount of histamine released ex vivo from ear skin into media when floated overnight (c) and in vivo into
the serum (d) (WT n = 3, Igh7–/– n = 4). (e) Representative images of H&E-stained cross-sections from inflamed TPA-treated ear skin of WT and Igh7–/–
mice. (f) Epidermal thickness is enumerated. Data in (a–d, f) are expressed as means ± SEM. One-way ANOVA multiple comparison was used to assess
statistical difference; *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. UT = untreated; ns = not significant.
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. The cellular immune composition of inflamed skin is unaltered in the absence of IgE-mediated signalling.
Figure supplement 2. FceRI+ cells from inflamed skin produce type-two cytokine proteins.
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Figure 5. IgE activity in inflamed skin is mediated via FceRI-signalling in basophils. (a–d, h) Healthy untreated (UT) ear skin of mice was examined and
compared to inflamed TPA-treated skin (topical TPA 2x/week for 2 weeks). (a) Mast cells and basophils were FACS sorted from the skin of WT and
Igh7–/– mice and (b) basophils were sorted from the spleen of WT mice 72 hr after the last TPA treatment (n = 3/group). Mast cells were defined as
CD45hicKit+FceRI+CD41– and basophils as CD45locKit–FceRI+CD41+. (a, b) Quantitative RT-PCR analysis of the levels of Il4, Il6 and Il13 transcripts in the
Figure 5 continued on next page
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that are stimulated with TSLP or IL-3, which are abundantly expressed in inflamed skin (Figure 6h
and Dalessandri and Strid, 2014), (or with PMA/ionomycin as a control) showed upregulated
expression of CXCR4 on the cell surface (Figure 6i–k). De novo expression of CXCR4 RNA was
induced by TSLP (Figure 6i), and the intracellular pool of CXCR4 protein was transported to the cell
surface when basophils were stimulated with TSLP or IL-3 (Figure 6j,k). As IL-3 is classically produced
by T cells, we next examined the effect of depleting T cells, and found a complete lack of basophil
recruitment to the inflamed skin of mice lacking all T cells (Figure 6l). In support, we found that
reducing IL-3 levels during skin inflammation by intradermal injection of neutralising antibodies also
reduced the recruitment of basophils (Figure 6m). Similarly, blocking TSLP significantly reduced
basophil recruitment to inflamed skin and blocking TSLP and IL-3 simultaneously abolished basophil
recruitment (Figure 6m). Injection of blocking antibodies intradermally in one ear also blocked
recruitment into the inflamed skin in the contralateral ear (Figure 6n), suggesting that the cytokine
(s) were acting systemically and not locally on basophil recruitment. In vitro experiments showed
that IL-3/TSLP were not chemotactic themselves but that basophils demonstrated chemotaxis
towards CXCL12 (Figure 6—figure supplement 1). Together these data show that production of
TSLP and IL-3 in inflamed skin drives the surface expression of CXCR4 on systemic basophils, allow-
ing recruitment to the skin in response to increased levels of CXCL12.
FceRI-signalling in basophils promotes inflammation-driven outgrowth
of cSCCs
As natural IgE promoted EC growth via FceRI-signalling in basophils during skin inflammation, we
next tested whether a similar mechanism may support skin tumour growth. Using the two-stage
inflammation-driven model of epithelial carcinogenesis, we found that mice lacking FceRI (Fcer1a–/–)
were significantly less susceptible to tumour development (Figure 7a). Only few mice developed any
tumours at all and the tumours that grew were very small (Figure 7a). Nevertheless, the composition
of the immune infiltrate in both the perilesional skin and the tumour tissue was overall similar in
Fcer1a–/– and WT mice, apart from a minor reduction in neutrophils in the tumours from Fcer1a–/–
mice (Figure 7b). Further, mice with substantially diminished FceRI effector cells, Cpa3Cre/+ mice,
were also significantly protected from tumour development (Figure 7c). Cpa3Cre/+ mice lack all
mature skin mast cells as a result of Cre toxicity (Feyerabend et al., 2011) and no mast cells were
found in either perilesional skin or tumour tissue (Figure 7d). However, these mice also have sub-
stantially reduced basophil numbers with >90% reduction in inflamed skin and perilesional skin,
although basophils were detected in the tumour (Figure 7d). Owing to the dual effect of
the Cpa3Cre on mast cells and basophils , we next used Mcpt8Cre/+ mice, which have normal mast
cell numbers but a strongly reduced number of basophils (Figure 7f). The Mcpt8Cre/+ mice were
again significantly less susceptible to tumour growth (Figure 7e), suggesting that FceRI-signalling in
basophils was responsible for tumour growth. As signalling via histamine receptors H1R and/or H4R
on EC were shown to promote EC proliferation and differentiation during skin inflammation, we
then tested whether blocking H1R affected tumour outgrowth. Indeed, adding cetirizine, a H1R
blocker, to the drinking water during tumour promotion significantly delayed tumour onset and
Figure 5 continued
FACS-sorted cell populations from the indicated tissues relative to levels of the control gene cyclophilin. (c) ELISA assessing the amount of histamine
released ex vivo from ear skin into media when floated overnight (left panel) and in vivo into the serum (right panel) of WT, FceR1a–/– and Mcpt8Cre/+
mice (n = 3/group). (d) Epidermal thickness measured from H&E-stained cross-sections of WT and Mcpt8Cre/+ ear skin (n = 5/group). (e–g) Neonatal WT
skin EC (keratinocytes) were grown in vitro to 70% confluency and then supplemented with (e) media from IgE-crosslinked basophils or media alone or
(f) differing concentrations of histamine (n = 3/group). Histamine receptors on ECs were blocked by adding 10 mM H1R- or H4R-antagonist or both to
cultures with added histamine (f) or basophil media (g) (n = 3/group). (e–g) EC were analysed by qRT-PCR for the expression levels of transcripts
indicating cell cycling (Ki67) and differentiation (K5, K14, K1 and K10) relative to the expression level of the control gene cyclophilin. (h) Epidermal
thickness measured from H&E-stained cross-sections of WT ear skin following in vivo blocking of H1R or H4R by i.p. administration of antagonist drug or
vehicle control (n = 5/group). All data are expressed as means ± SEM. Statistical analysis was performed by one-way ANOVA multiple comparison (a–d,
f–h) or two-tailed Student’s t-test (e); *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. UT = untreated; ns = not significant.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Basophils are potently immune active in inflamed skin but require IgE for full activity.
Figure supplement 2. IgE-activated basophils promote cytokine expression in skin EC.
Hayes et al. eLife 2020;9:e51862. DOI: https://doi.org/10.7554/eLife.51862 11 of 24
Research article Cancer Biology Immunology and Inflammation
bCCL2 CCL5 CCL8 CCL11 CCL24 CXCL2 CXCL8 CXCL12
Ch
em
o
ki
n
es
 
(re
la
tiv
e 
x
10
-
2 )
0
0.4
1
5
20
*
0.2
0.6
0.8
1.2
10
15
*
*
*
**
UT
TPA
0
0.05
0.10
0.15
0.20
0.5
1.0
1.5
2.0
CCR1
CCR2
CCR3
CCR5
CXCR2
CXCR4
CrTH2
Basophils Mast cells
Ch
em
o
ki
n
e 
re
ce
pt
o
rs
 
(re
la
tiv
e)
a
15
20
25
30
B
as
o
ph
ils
 
(x1
03
)
*
*
Vehicle
0.4?g PTX
0.8?g PTX
0
5
10
15
20
B
as
o
ph
ils
 
(x1
03
)
0
10
20
30
40
N
eu
tr
o
ph
ils
 
(x1
04
) Isotype
?-CXCR2
*
****
0
10
20
30
40
M
o
n
o
cy
te
s 
(x1
04
)
ns ****
WT UT
WT TPA
Ccr2-/- UT
Ccr2-/- TPA
dc
e
Isotype
?-CXCR4
****
0
10
20
30
B
as
o
ph
ils
 
(x1
03
)
****
WT
Tcrb-/-
Tcrd-/-
Tcrbd-/-
****
**
****
Isotype
?-TSLP
Isotype
?-IL-3
?-TSLP+?-IL-3
0
5
10
15
B
as
o
ph
ils
 
(x1
03
)
Isotype
?-TSLP
Contralateral 
?-TSLP
****
****
CX
CR
4 
(re
la
tiv
e 
x
10
-
2 )
0
5
10
15
Media
+TSLP
***
l
f
m n
CXCR4 0
20
40
60
80
CX
CR
4+
 
ba
so
ph
ils
 
(%
)
0
500
1000
1500
CX
CR
4+
 
ba
so
ph
ils
 
(M
FI
)
**
**
Surface
IntracellularIsotype
Surface
Intra-
cellular
g
UT
Activated
UT
Isotype
P/I
TSLP
IL-3
CXCR4
0
20
40
60
80
100
CX
CR
4+
 
ba
so
ph
ils
 
(%
)
0
2000
4000
6000
8000
CX
CR
4+
 
ba
so
ph
ils
 
(M
FI
)
Isotype
UT
IL-3
TSLP
P/I
****
****
****
ns
*
***
****
j k
i
CXCR4 CD45 OverlayBF
TSLP IL-3
UT
TPA
h
0
2
4
20
40
60
Cy
to
ki
n
es
 
(re
la
tiv
e 
x
10
-
2 )
**
**
25
0
5
10
15
20
B
as
o
ph
ils
 
(x1
03
)
25
0
10
20
B
as
o
ph
ils
 
(x1
03
)
30
0
5
10
15
20
B
as
o
ph
ils
 
(x1
03
)
25
**
Figure 6. Basophil recruitment to the skin requires TSLP/IL-3-mediated upregulation of CXCR4. (a–f, h, l–n) Inflamed skin was analysed 24 hr after a
single topical application of 2.5 nM TPA and compared to healthy UT skin. (a) Recruitment of basophils to inflamed skin was analysed by FACS and
presented as absolute numbers of basophils in ear skin following i.v. injection of PTX or vehicle control. Basophils were gated as
CD45locKit–IgE+CD41+. (b) Expression of chemokines in whole skin and (c) expression of chemokine receptors in sorted skin basophils and mast cells
Figure 6 continued on next page
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suppressed tumour growth (Figure 7h). Together these data demonstrate that the inflammation-
driven tumour promotion is mediated via FceRI-signalling in skin-infiltrating basophils, partly via his-
tamine release.
Discussion
In this study, we found that skin inflammation enhanced levels of natural IgE, which accumulated in
the tissue mainly on infiltrating basophils recruited via TSLP/IL-3-dependent expression of CXCR4.
IgE-activated basophils promoted EC growth and differentiation, and strongly drove the outgrowth
of inflammation-driven skin SCCs, partly via histamine engagement of H1R and H4R on EC.
Natural IgE is present at low concentrations in the blood of mice and men but is constitutively
available on FceRI-expressing cells at our barrier surfaces, such as the skin. Although the role of natu-
ral IgE at steady state has not been widely studied, it is suggested to be part of our ‘frontline’
immune defence against a variety of environmental challenges (such as parasitic infections) as well as
exposure to noxious xenobiotics, irritants and venoms (Palm et al., 2012; Profet, 1991). The host
defences that are evoked may include barrier enhancement, removal or inactivation of the challenge
and tissue repair (Palm et al., 2012; Profet, 1991). Our IgE sequencing analysis revealed that IgE
antibodies that are induced by low-grade tissue inflammation have a similar repertoire and VDJ
gene-usage to the natural IgE in healthy animals, suggesting that tissue inflammation merely enhan-
ces the level of IgE already present in the host. This natural IgE fortified the skin barrier defences by
inducing EC growth and differentiation and by thickening the epidermis. However, this response
should only be activated transiently upon exposure to noxious stimuli, because long-term exacerba-
tion of this response may lead to pathologies and altered EC function. Indeed, we found that when
EC harbour oncogenic mutations, chronic activation of the IgE response subverts its protective
effects and supports the growth of otherwise subclinical EC lesions, thereby promoting tumour
development.
The tumour-promoting effect of IgE in the context of chronic skin inflammation is in stark contrast
to our recently published data showing that IgE provides protection against mutagen-driven EC car-
cinogenesis (Crawford et al., 2018). Interestingly, the DNA-damage caused by repeated carcinogen
exposure drives a de novo induction of autoreactive IgE antibodies, which differ substantially in their
repertoire from the inflammation-induced IgE (Crawford et al., 2018). Repeated carcinogen expo-
sure also gives rise to substantially more mutated tumours than inflammation-driven skin carcinogen-
esis (Nassar et al., 2015), suggesting a different mode of tumour outgrowth in the different
experimental scenarios. Whole-exome sequencing of human cutaneous squamous-cell carcinoma
(cSCC) has identified this as one of the most mutated human cancers, with a mean of 50 mutations
per megabase of DNA (Inman et al., 2018). This sequencing has also revealed that there are signifi-
cantly more mutations in immune-related pathways, including in FceRI-signalling, in tumours of high-
versus low-risk of metastasis (Inman et al., 2018). We also found a significant positive correlation
Figure 6 continued
were analysed by qRT-PCR and presented relative to the expression of the control gene cyclophilin. (d–f) Recruitment of basophils to inflamed skin was
analysed as in panel (a): (d) after i.v. injection of 50 ng anti-CXCR2 antibody, (e) in Ccr2–/– mice, or (f) after i.v. injection of 50 ng anti-CXCR4 antibody.
Suitable control populations were used to show the efficacy of a treatment where appropriate. (g, i–k) Basophils were isolated from the spleen of WT
mice and (g) analysed for cell surface or intracellular expression of CXCR4 by flow cytometry. (h) Expression of IL-3 and TSLP in whole inflamed and
untreated (UT) skin was analysed by qRT-PCR and presented relative to the expression of the control gene cyclophilin. (i) Splenic basophils were
incubated with 1 mg/ml TSLP or media alone for 24 hr, and expression levels of CXCR4 transcripts were assessed by qRT-PCR. (j, k) Basophils were
activated for 24 hr with 100 ng/ml IL-3, 1 mg/ml TSLP or isotype control, with PMA/ionomycin for 4 hr, or left UT before surface expression of CXCR4
was analysed by (j) FACS or (k) total CXCR4 expression (yellow) imaged with surface staining of CD45 (red) using Imagestream. (l–n) Recruitment of
basophils to inflamed skin was analysed as in panel (a): (l) in Tcrb–/–, Tcrd–/– and Tcrbd–/– mice, (m) following intradermal (i.d.) injection of 20 ng anti-
TSLP or anti-IL-3 (or both) antibodies into the TPA treated ear or (n) into the contralateral ear. Representative data are shown in panels (g, j [left panels])
as histograms of CXCR4 FACS stain and in panel (k) as images from Imagestream; all other data are expressed as means ± SEM. Statistical analyses
were performed by one-way ANOVA multiple comparison (a–c, e, g, j, l–n) or two-tailed Student’s t-test (d, f, h–i); *p<0.05, **p<0.01, ***p<0.001 and
****p<0.0001. UT = untreated; ns = not significant; BF = bright field.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. Basophils demonstrate chemotaxis towards CXCL12.
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Figure 7. FceRI-signalling in basophils promotes inflammation-driven outgrowth of cSCCs. (a–h) Mice were treated with a single subclinical dose of
DMBA to the shaved dorsal back skin, and skin inflammation was promoted by twice weekly TPA application for 18–25 weeks. Tumour susceptibility is
expressed as tumour latency (time to appearance of first tumour), tumour incidence (average number of tumours per mouse) and tumour area (average
tumour size per mouse) in (a) WT (n = 10) and FceR1a–/– mice (n = 9), (c) WT (n = 10) and Cpa3Cre/+ mice (n = 8), (e) WT and Mcpt8Cre/+ mice (n = 9/
Figure 7 continued on next page
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between FCER1A-expression in human cSCC and good disease prognosis (Crawford et al., 2018),
which may reflect a broader paradigm as FCER1A-expression correlates with overall prolonged sur-
vival in many human malignancies (Gentles et al., 2015). Thus, although the commonly used inflam-
mation-driven cutaneous carcinogenesis mouse model (DMBA-TPA; also used in this study) exhibits
recurrent mutations in genes similar to those mutated in human cSCC (Hras, Kras, Rras2 or Trp53)
(Nassar et al., 2015), the low level of mutations may alter the immunogenicity and the microenviron-
mental niche in which the tumour grows, which may in part explain the paradoxical role of IgE in this
model. Together, our previous (Crawford et al., 2018) and current studies show a potent link
between IgE and cancer. However, the biological consequences of IgE engagement clearly depend
on the nature of the antibodies and the tissue microenvironment.
Chronic inflammation has frequently been linked to cancer promotion, and tumour extrinsic
inflammatory conditions may be key to the development of selected cancers. Epidemiological stud-
ies suggest that low-grade tissue inflammation predisposes tissues to different forms of cancer by
contributing to the proliferation and survival of malignant cells, by promoting angiogenesis and
tumour metastasis and by subverting anti-cancer immunity (Mantovani et al., 2008;
Coussens et al., 2013; Grivennikov et al., 2010). For example, gastric and bladder cancers have
long been known to be driven by inflammation (Fox and Wang, 2007; Echizen et al., 2019;
Michaud, 2007). Interestingly, RNAseq data in these two cancers, contrary to that in many other
cancers, suggests a negative correlation between FCER1A and overall survival (KMplotter;
Nagy et al., 2018). A recent study also revealed increased mast cell density in human gastric
tumours and in the corresponding mouse models, and showed that mast cell degranulation was driv-
ing tumour growth (Eissmann et al., 2019). It should be noted that in this study mast cell numera-
tion was performed using toluidine blue, which also stains basophils. Although IgE/FceRI-signalling
has not been linked directly to tumour growth in these cancers, taken together, these data suggest
that IgE may play a role in cancer promotion in inflammatory settings in some human tissues.
IgE-mediated immune surveillance in the skin is most probably dominated by mast cells in healthy
skin and during the early-phase response (as is immune surveillance in allergic disease), whereas the
late-phase response is driven by recruited basophils. In our study, basophils were dominant over
mast cells in the inflamed skin, and only basophils appeared to enter the tumours, whilst mast cells
remained at the base of the tumours and in the surrounding tissue. Epidermal hyperplasia during tis-
sue inflammation was driven by FceRI-signalling in basophils, and tumour growth also appeared to
be promoted mainly by basophils, although we cannot exclude a role for mast cells because Cpa3-
Cre/+ mice (which lack mast cells and most basophils) were more protected from carcinogenesis than
Mcpt8Cre/+ mice (which have normal mast cell numbers but lack most basophils). Further, mast cells
have previously been shown to support SCC growth in tumour models driven by human papilloma
virus (Coussens et al., 1999; Bergot et al., 2014) and indeed may contribute to the tumour promo-
tion shown in our study. Nevertheless, other skin cancer studies have not found a clear role for mast
cells in tumour progression or even shown an anti-tumourogenic role; thus, the role of mast cells in
skin cancer development remain controversial and most probably depends on the underlying factors
driving the disease (Varricchi et al., 2017). Although the physiological role of basophils remain
poorly understood, it is increasingly recognised that basophils regulate immunity at many levels,
often distinct from mast cells (Voehringer, 2013; Karasuyama et al., 2009; Schwartz et al., 2016).
For example, skin-infiltrating basophils, but not mast cells, have been shown to be crucial for
acquired tick resistance in mice (Tabakawa et al., 2018). Interestingly, the mechanism of basophil-
mediated tick host defence is by epidermal thickening driven by local histamine release
Figure 7 continued
group) and (h) WT mice given the H1R antagonist cetirizine at 30 mg/kg or vehicle control in the drinking water throughout the experiment (n = 10/
group). (b) FACS analysis of leukocyte infiltrate in tumour tissue and perilesional skin of WT and FceR1a–/– mice (n = 7 for WT groups; n = 3 for tumour,
n = 7 for peri-lesional tissue for FceR1a–/–) presented as proportion of total CD45+ leukocytes. (d, f) FACS analysis of mast cells and basophils in
tumours and peri-lesional tissue of (d) WT and Cpa3Cre/+ mice (n = 6 for WT groups; n = 3 for tumour, n = 6 for peri-lesional tissue for Cpa3Cre/+) and of
(f) WT and Mcpt8Cre/+ mice (n = 5/group). Data are expressed as means ± SEM, and statistical significance was assessed using Log-rank (Mantel-Cox)
test for tumour latency and linear regression for tumour incidence and area (a, c, e, h) and one-way ANOVA multiple comparison (b, d, f); p<0.05,
**p<0.01 and ****p<0.0001.
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(Tabakawa et al., 2018), consistent with the role of basophils and histamine in EC growth demon-
strated in our study.
Histamine has wide-ranging effects on skin ECs and has previously been shown to promote
wound healing in the skin (Gutowska-Owsiak et al., 2014). For a long time, the effects of histamine
in skin diseases have been thought to be mediated solely by its action on H1Rs, however newer find-
ings, including this report, suggest that H4R-signalling strongly affects skin ECs. H4R-deficient mice
have thinner epidermis than WT mice at steady state (Glatzer et al., 2013). Furthermore, H4R-defi-
ciency or blockade significantly reduces epidermal hyperplasia (Rossbach et al., 2016) and total skin
thickness (Cowden et al., 2010) in inflammatory settings. Surprisingly, mice lacking histidine
decarboxylase (HDC) (the enzyme responsible for histamine generation) are more susceptible to
inflammation-induced carcinogenesis of the skin and colon (Yang et al., 2011). However, this is due
to an important role for histamine in myeloid cell differentiation and maturation within the bone mar-
row (through H1R and H2R), and HDC-deficient mice have significantly altered myeloid cell composi-
tion including a large increase in immature myeloid cells, which are recruited to the tissue during
inflammation and promote cancer growth (Yang et al., 2011).
In summary, we demonstrate how IgE antibodies with natural specificities regulate skin EC growth
and differentiation via FceRI-signalling. Further, during chronic skin inflammation, IgE strongly pro-
motes outgrowth of ECs harbouring oncogenic mutations. Thus, our data suggest a potential link
between autoreactive IgE and skin hyperplasia, which may be pertinent for a variety of inflammatory
skin conditions in which the blocking of IgE-mediated signalling could be beneficial, as has been
shown for idiopathic urticaria (Maurer et al., 2011; Maurer et al., 2013). Moreover, our data may
have potential important implications for both atopy and cancer.
Materials and methods
Mice
Genetically altered mice were generated as previously described. Igh-7–/– (Oettgen et al., 1994),
Fcer1a–/- (Dombrowicz et al., 1993), Cpa3Cre/+ (Feyerabend et al., 2011) and Mcpt8Cre/+
(Ohnmacht et al., 2010) were on the BALB/c background after more than 10 backcrosses. Tcrd–/–
(Itohara et al., 1993) and Tcrb–/– (Mombaerts et al., 1991) were on the FVB/N background after
more than 10 backcrosses and Tcrdb–/– were generated by intercrossing the respective mutants.
Ccr2–/– (Boring et al., 1997) mice were on the CD1 background. Non-transgenic littermates were
used as controls or strain-matched wild-type control animals were purchased from Charles River.
Mice were bred and maintained in individually ventilated cages under specific pathogen-free condi-
tions. Age-matched, female mice were used for all experiments at 7 weeks of age and selected at
random from a large pool when allocated to experiments. All studies were approved by Imperial
College AWERB (Animal Welfare and Ethical Review Body) and by the UK Home Office. Experiments
involving cancer studies strictly adhered to the guidelines set out by the National Cancer Research
Institute (NCRI) and by Workman et al. (2010), ‘Guidelines for the Welfare and Use of Animals in
Cancer Research’. All studies using animals were conducted following the Animal Research: Report-
ing In Vivo Experiments (ARRIVE) guidelines (Kilkenny et al., 2010).
Cutaneous challenge and chemical carcinogenesis
Chemicals 12–0-tetradecanoylphorbol-13-acetate (TPA), MC903 and 7,12-dimethylbenz[a]anthracene
(DMBA) were purchased from Sigma, R848 from Enzo Life Sciences and they were dissolved in etha-
nol (TPA, MC903) or acetone (DMBA, R848). Skin inflammation was induced by exposing the dorsal
sides of the ear skin to a single or repeated dose of 2.5 nM TPA, 1 nM MC903 or 100 mg R848 in 25
ml.
For cutaneous carcinogenesis, age-matched female mice were used at 7 weeks of age. The fur of
the dorsal back area was removed using hair clippers and mice were rested for 1 week. Applications
of chemicals and tumour monitoring were performed as previously described (Strid et al., 2008). In
brief, 600 nM DMBA was carefully and slowly applied by pipette, in a 150 ml volume, to the entire
clipped skin area. Mice were rested for one week and 20 nM TPA was then applied twice weekly.
Hair regrowth during the experiment was gently removed by clipping with trimmers. Mice were
monitored daily and cutaneous tumours were counted and measured with a calliper once weekly.
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Back skin and tumours were evaluated by visual inspection by an observer blinded to the experimen-
tal groups.
Tissue processing
Skin and tumour tissues were cut into small 1 mm2 pieces using a scalpel blade and incubated for 2
hr in digestion buffer containing 25 ug/ml liberase (Roche), 250 ug/ml DNAseI (Roche) and 1x
DNAse buffer (1.21 Tris base, 0.5 g MgCl2 and 0.073 g CaCl2) at 37˚. Following digestion, tissue was
transferred into C-tubes (Miltenyi Biotech) containing RPMI-1640 media (Thermo Fisher) supple-
mented with 10% heat-inactivated foetal calf serum, 1% penicillin-streptomycin-glutamine (Thermo
Fisher) and physically disrupted using a Miltenyi cell dissociator. Spleen and LN tissue was disaggre-
gated mechanically using a rubber policeman. All cell suspensions were filtered and cells
were counted using a CASY cell counter (Roche).
Dermal sheets
Ears were collected, split into dorsal and ventral sides and floated dermis side down in 0.5 M
NH4SCN for 40 min, 37˚C and 5% v/v CO2. Subsequently, intact dermal sheets were isolated and
washed in PBS. They were then fixed in ice-cold acetone at –20˚C for 15 min, followed by rehydra-
tion in PBS and blocking of nonspecific binding with 2% BSA for 1 hr. IgE in the tissue was visualised
by first incubating with rat anti-mouse IgE (R35-92, BD) followed by Alexa Fluor 555–conjugated
goat anti-rat IgE (A21434, ThermoFisher), each for 1 hr at room temperature. After extensive wash-
ing in PBS, samples were mounted in VectaShield containing DAPI (Vectashield) and visualised with
a Leica SP5 confocal laser-scanning microscope (Leica).
Epidermal thickness
The dorsal sides of the ears were treated topically twice a week for 3 weeks with 2.5 nM TPA and
subsequently fixed and paraffin embedded. Ear skin from untreated mice or the untreated contralat-
eral ear was embedded in parallel. 5 mm sections were cut and stained for H&E. Images were
obtained using a Leica DM4B microscope (Leica). Epidermal thickness was measured using Fiji soft-
ware by taking five measurements per section from five sections per ear in a blinded manner. In
some experiments, H1R or H4R antagonist was administered by i.p. injection of 20 mg/kg cetirizine
dihydrochloride (Tocris) or 20 mg/kg JNJ 7777120 (Tocris), respectively, or of the appropriate vehi-
cle controls.
Immunofluorescent staining of skin and tumour samples
For ear skin, ears were removed and a defined central section cut. Tumours were removed from the
back of the ears along with a small piece of adjacent skin. All tissues were snap-frozen in OCT on
dry ice. 6 mm sections were cut using a Leica JUNG CM1800 cryostat and stored at –80˚C.
For staining, slides were returned to room temperature before fixation with 4% paraformaldhyde
for 15 min. Samples were then blocked in 5% goat serum for 1 hr at room temperature before stain-
ing with rat anti-mouse IgE (R35-92, PharMingen) overnight at 4˚C. Following staining, samples were
washed and incubated with Alexa Fluor 555–conjugated goat anti-rat IgG (A21434, ThermoFisher).
After extensive washing, samples were then either further incubated with Alexa Flour 647-conju-
gated rat anti-mouse CD49F (GoH3, BioLegend) or directly mounted in VectaShield containing DAPI
(Vectashield). Tissue samples were visualised with a Leica SP5 confocal laser-scanning microscope
(Leica).
Flow cytometry, cell sorting and Imagestream
Cell suspensions were blocked for non-specific binding using antibody against FcgR (2.4G2) and 2%
normal rat serum (Sigma) prior to any staining protocols. For staining of cell surface markers, cell sus-
pensions were stained with fluorochrome-conjugated antibodies or appropriate isotype control with
the addition of a fixable, live/dead discrimination dye (Invitrogen) for 25 min and subsequently
washed. Intracellular staining was then carried out using an Intracellular Staining kit as per manufac-
turer’s instructions (ThermoFisher Scientific). Cells were fixed for 10 min at 4˚C, washed with Perm
buffer and stained for intracellular markers for 25 min. For intranuclear gH2AX staining, cells were
fixed/permeablised in ice-cold 70% ethanol at  20˚C for 2 hr, blocked with 2% normal mouse serum
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(Sigma), Fc-block and 2% fetal calf serum for 15 min, followed by 45 min staining for gH2AX at room
temperature. Stained cells were analysed using BD FACSVerse and Fortessa X20 (BD Biosciences,
NJ, USA) machines. Data analysis was performed using FlowJo 10 for Mac (TreeStar, OR, USA). For
cell sorting, a FACS AriaIII High Speed Cell Sorter (BD) was used. For Imagestream analysis, internal-
isation scores were determined using CD45 staining as a membrane marker and CXCR4 staining as
the probe. Analyses were performed using an ImageStream X Mark II imaging flow cytometer and
IDEAS v6 software (AMNIS).
Antibodies were sourced from Biolegend unless otherwise stated. The following antibodies were
used: anti-CD11b (M1/70), anti-Siglec-F (E50-2440), anti-Ly6C (HK1.4), anti-Ly6G (IA8), anti-CD4
(GK1.5), anti-CD8 (53–6.7), anti-CXCR4 (I.276F12), anti-CD138 (281–2, BD) anti-CD45 (30-F11, eBio-
science), anti-IgE (23G3, eBioscience), anti-TCRb (H57-597), anti-TCRgd (eBioGL3, eBioscience), anti-
Vg5 (536, eBioscience), anti-Vg4 (UC3-10Ab), anti-CD117 (2B8), anti-CD41 (MWReg30), anti-FceRI
(MAR-1), anti-CD95 (Jo2, eBioscience), gH2AX (JBW301, Millipore), anti-IL-4 (11B11, eBioscience),
anti-IL-5 (TRFK5) and anti-IL-13 (eBio13A, eBioscience).
Cells subsets were gated on live singlets for all and then as: mast cells — CD45+CD117+IgE/
FceRI+CD41–; basophils — CD45midCD117–IgE/FceRI+CD41+; eosinophils — CD45+GR1+CD11b+-
Siglec-F+; neutrophils — CD45+Ly6G+Ly6C–CD11b+; monocytes/macrophages — CD45+CD11b+-
Ly6G–Ly6C+; abT cells — CD45+Tcrb+CD4/CD8+; gd IEL — CD45+TcrdhiVg5+; dermal gd T cell —
CD45+Tcrd+Vg5-; plasma cell — FSChiCD95+CD138+.
ELISA
Total IgE was measured by an IgE capture method. Sera to be tested and IgE standard were added
to plate wells coated with 1 mg/ml rat monoclonal anti-mouse IgE (PharMingen) and blocked with
1% rat serum. Biotinylated rat monoclonal anti-mouse IgE (PharMingen) at 1 mg/ml were then added
and incubated for 2 hr at 37˚C. After washing in PBS 0.05% Tween, plates were incubated with alka-
line phosphatase-conjugated Streptavidin (PharMingen) for 1 hr at 37˚C. After washing, detection of
antibody levels was carried out by addition of alkaline phosphatase substrate pNPP (Sigma) and
absorbance was measured at 405 nm. For detection of anti-phosphorylcholine (anti-PC) specific IgE,
total IgE was captured with anti-mouse IgE (PharMingen), followed by addition of PC-BSA at 50 mg/
ml (Sigma). After washing, detection was achieved by incubating first with anti-PC IgM antibody
(clone BH8) (Millipore), followed by anti-IgM conjugated to alkaline phosphatase (Southern Biotech)
and addition of pNPP substrate (Sigma). Absorbance was measured at 405 nm. Detection limit was
3 ng/ml.
For IgG1 and IgG2a antibodies, NUNC Immune Maxisorp 96-well plates (Thermo Scientific) were
coated with 5 mg/ml goat anti-mouse IgH+L (Southern Biotech) in borate buffered saline at 37˚C for
3 hr. After washing, plates were blocked with PBS containing 0.5% BSA for 1 hr at room tempera-
ture, and appropriately diluted sera added and incubated overnight at 4˚C. After washing, plates
were incubated with alkaline phosphatase-conjugated polyclonal goat anti-mouse IgG1 or IgG2a
(which also detects IgG2c in C57BL/6 mice) (both Southern Biotech) for 5 hr at 4˚C. Following further
washing, the alkaline phosphatase substrate pNPP (Sigma) was added and absorbance measured at
405 nm.
Histamine levels in serum and ear supernatant were measured using an ultra-sensitive histamine
ELISA kit (Enzo Life Sciences) following the manufacturer’s instructions. Skin supernatant was
acquired by floating the dorsal ear skin on 250 ml of complete media for 16 hr.
qRT-PCR and primer sequences
RNA was extracted from isolated cell suspensions or from skin/tumour tissue, and preserved in RNA-
later, using RNEasy Mini kits (Qiagen). RNA was dissolved in nuclease-free water, and yield and
purity were determined. Complementary DNA (cDNA) was synthesised from RNA with an iScript
cDNA synthesis kit (Bio-Rad) as per the manufacturer’s instructions. cDNA was diluted in nuclease-
free double-deionized water for qRT–PCR. All primers were single-stranded DNA oligonucleotides
(Sigma) that were intron-spanning, as verified by NCBI Primer-Blast tool. Real-time PCR products
were detected with SYBR Green (Life) measured continuously with a ViiA 7 Real-Time PCR system
(Applied Biosystems, CA, USA). Ct values for genes of interest were normalised against Ct values of
the housekeeping gene Cyclophilin (Cyc) using the 2–DCt method. The following primers were
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used — IL-1a: F (50- TTGGTTAAATGACCTGCAACA-30), R (50-GAGCGCTCACGAACAGTTG-30), IL-4:
F (50-CATCGGCATTTTGAACGAG-30), R (50-CGAGCTCACTCTCTGTGGTG-30), IL-5: F (50-GAAAGA-
GACCTTGACACAGCTG-30), R (50-GAACTCTTGCAGGTAATCCAGG-30), IL-6: F (50-TGATGGATGC
TACCAAACTGG-30), R (50-TTCATGTACTCCAGGTAGCTATGG-30), IL-13: (50-ACACAAGACCAGAC
TCCCC-30), R (50-CTCCTCATTAGAAGGGGCCG-30), IL-18: F (50-ACATCTTCTGCAACCTCCAGCA-
30), R (50-CATTGTTCCTGGGCCAAGAGG-30), IL-25: (50- TGGAGCTCTGCATCTGTGTC-30), R (50-GA
TTCAAGTCCCTGTCCAACTC-30), IL-31: F (50-GGCCTTCCTCACTCTCTTAC-30), R (50-GTATAG-
GAACCTGGCTGGC-30), IL-33: F (50-CACATTGAGCATCCAAGGAA-30), R (50-AACAGATTGGTCA
TTGTATGTACTCAG-30), TNFa: F (50-AGCCCACGTAGCAAACCACCA-30), R (50-ACACCCATTCCC
TTCACAGAGCAAT-30), Ki67: F (50-TCTGATGTTAGGTGTTTGAG-30), R (50-CACTTTTCTGGTAACTTC
TTG-30), K1: F (50-TTTGCCTCCTTCATCGACA-30), R (50-GTTTTGGGTCCGGGTTGT-30), K5: F (50-CC
TGCAGAAGGCCAAGCA-30), R (50-TGGTGTTCATGAGCTCCTGGTA-30), K10: F (50-GGATGAGC
TGACCCTTAGCA-30), R (50-CATTTTGAAGGTCTCTCATTTCCT-30), K14: F (50-CAGCCCCTAC
TTCAAGACCA-30), R (50-GGCTCTCAATCTGCATCTCC-30), Cpa3: F (50-CTACGGCCCAATAGCA
TCCA-30), R (50-TGCCCAGGTCATAAACCCAG-30), Mcpt8: F (50-CAGTCTATCGCTGTGGTGGT-30), R
(50-GAGCTTTGCGTTCCAGCTTC-30), HDC: F (50-GAGTGCACAGCACAGACAAAGG-30), R (50-TC
TAGCTCGGTAGTATTCACT-30), Ptgds: F (50-GACACAGTGCAGCCCAACTTTC-30), R (50-GGGCTAC-
CACTGTCTTGCACATA-30), Hpgds: F (50-ATCCACCAGAGCCTCGCAATAG-30), R (50-TCATCCAGCG
TGTCCACCA-30), Ptges1: F (50-GGATGCGCTGAAACGTGGA-30), R (50-CAGGAATGAGTACAC-
GAAGCC-30), Ptges2: F (50-CTCATCAGCAAGCGCCTCAA-30), R (50-GGTCTTTACCCACGGCTGTCA-
30), Ptges3: F (50-ATCACATGGGTGGTGATGAGGA-30), R (50-AGGCGATGACAACAGCCCTTAC-30),
CCL2: F (50-CCCAATGAGTAGGCTGGAGA-30), R (50-AAAATGGATCCACACCTTGC-30), CCL5: F (50-
TGCCCACGTCAAGGAGTATTTC-30), R (50-AACCCACTTCTTCTCTGGGTTG-30), CCL8: F (50-CCC
TTCGGGTGCTGAAAAG-30), R (50-TCTGGAAAACCACAGCTTCCA-30), CCL11: F (50-ATGCACCC
TGAAAGCCATAGTC-30), R (50-CAGGTGCTTTGTGGCATCCT-30), CCL24: F (50-CGGCCTCCTTCTCC
TGGTA-30), R (50-TGGCCAACTGGTAGCTAACCA-30), CXCL2: F (50-CGCTGTCAATGCCTGAAG-30),
R (50-GGCGTCACACTCAAGCTCT-30), CXCL8: F (50-CTCTTGGCAGCCTTCCTGATT-30), R (50-TA
TGCACTGACATCTAAGTTCTTTAGCA-30), CXCL12: F (50-GAGCCAACGTCAAGCATCTG-30), R (50-
CGGGTCAATGCACACTTGTC-30), CCR1: F (50-AAGGCCCAGAAACAAAGTCT-30), R (50-TCTGTAG
TTGTGGGGTAGGC-30), CCR2: F (50-ACACCCTGTTTCGCTGTAGG-30), R (50-GATTCCTGGAAGG
TGGTCAA-30), CCR3: F (50-ATGGCATGTGTAAGCTCCTCTCAG-30), R (50-TTGCTCCGCTCACAGTCA
TTTCCCCR-30), CXCR2: F (50-AGCAAACACCTCTACTACCCTCTA-30), R (50-GGGCTGCATCAA
TTCAAATACCA-30), CXCR4: F (50-TCAACCTCTACAGCAGCGTTCTCTT-30), R (50-TGTTGGTGGCG
TGGACAAT-30), CrTH2: F (50-TCTCAACCAATCAGCACACC-30), R (50-CCTCCAAGAGTGGACA-
GAGC-30), Cyc: F (50-CAAATGCTGGACCAAACACAA-30), R (50-CCATCCAGCCATTCAGTCTTG-30).
Immunoglobulin sequencing and analysis
Mice were treated with TPA, which was applied to the dorsal side of the ear skin twice a week for 2
weeks. 48 hr after the last exposure, draining-LNs were collected and plasma cells
(FSChiCD95hiCD138+) cell sorted on a BD FACS Aria III (BD Biosciences, NJ, USA). RNA was
extracted using RNEasy Micro kits (Qiagen) and reverse transcribed using SuperScript III Reverse
Transcriptase (ThermoFisher). RNA was also collected from whole spleens of naı¨ve mice and reverse
transcribed similarly. Sequences were amplified using Phusion High-Fidelity DNA Polymerase (New-
England Biolabs) to ensure accuracy and robust performance for large PCR products. PCR with a
primer in the constant Ce region 50-CTAGGGTCATGGAAGCAGTGCC-30 in combination with a pro-
miscuous V region primer 50-GAGGTGCAGCTGCAGGAGTCTGG-30 was performed. Primers were
labelled at either end with Multiplex Identifiers (MIDs) for multiplexing. PCR thermal cycling was as
follows: 98˚C, 30 s; 30x (98˚C, 30 s; 60˚C, 30 s; 72˚C, 35 s); and 72˚C, 10 min. Amplicons were purified
by gel extraction using QIAquick PCR purification kit (Qiagen) and deep-sequenced by long-read
454 pyrosequencing on the Genome Sequencer FLX system (Roche). Raw sequencing data were pre-
sented in FASTA format and unproductive sequences were removed (data clean-up
stages were performed as described by Wu et al., 2015).
Analysis was performed as previously described (Wu et al., 2015). In short, sequences were
assigned to individual samples according to their MID. V(D)J gene assignments of individual sequen-
ces were annotated using IMGT/HighV-Quest and the mouse database. Physiochemical properties
Hayes et al. eLife 2020;9:e51862. DOI: https://doi.org/10.7554/eLife.51862 19 of 24
Research article Cancer Biology Immunology and Inflammation
of the CDRH3 region were calculated using the R package peptides. Physiochemical properties
included length, isoelectric point (pI) and frequencies of amino acid classes in the CDRH3 region.
Bone marrow-derived basophils and mast cells
Bone marrow was obtained from tibias and femurs of 8–10-week-old BALB/c mice and erythrocytes
depleted using Lysis Buffer Hybri-MaxTM (Sigma). Cells were washed and seeded in T25 flasks (TPP
Tissue Culture Flasks, Sigma) in 10 ml RPMI supplemented with 10% heat inactivated foetal bovine
serum (Gibco, Life Technologies), 1x penicillin streptomycin glutamine (PSG) (Gibco), 0.1 mM 2-mer-
captoethanol (Gibco) and 10 ng/mL rIL-3 (PeproTech, London, UK). Cells were incubated at 37˚C,
5% CO2 in a humidified incubator and the media were refreshed every 5 days. Basophil numbers
would peak after ~14 days and mast cells after ~1 month. For some experiments, cells were loaded
with purified mouse IgE antibodies (BD) at 0.5 mg/mL for 24 hr and subsequently crosslinked with
anti-IgE (R35-72, BD) at 5 mg/mL. IgE-crosslinked cells were harvested for qRT-PCR analyses and the
supernatants stored.
Primary neonatal keratinocyte cultures
Total body wall skin from neonatal mice (<5 days old) was incubated overnight at 4˚C in 5 U/ml Dis-
pase (BD) supplemented with 1x antibiotic and antimycotic solution (Sigma). The epidermis was iso-
lated and further digested in TrypLE Express supplemented with 200 mg/ml DNAse I and DNAse
buffer. Cell suspensions were filtered and resuspended in defined KC serum-free medium with sup-
plements (Life) and 1x antibiotic–antimycotic solution. Keratinocytes were seeded at an appropriate
cell density onto tissue culture vessels coated with rat-tail-derived collagen I (Sigma). Culture vessels
were washed with PBS 24 hr following seeding to remove unattached cells, and provided with fresh
medium with or without the addition of histamine (Sigma) or conditioned media from IgE-crosslinked
basophils. In some experiments, histamine receptors were blocked using 10 mM of the H1R antago-
nist cetirizine dihydrochloride or the H4R antagonist JNJ 7777120 (both from Tocris).
Cellular recruitment to the skin
To block cell recruitment to the skin, intradermal injections of 20 ng anti-TSLP, 20 ng anti-IL-3, both
or isotype controls were injected into the dorsal ear pinnae in a volume of 10 ml. In other experi-
ments, mice received i.v. injections of either 0.4 ug PTX or 0.8 ug PTX (Tocris), 50 ng anti-CXCR2 (R
and D), 50 ng anti-CXCR4 (R and D) or suitable controls. Skin inflammation was initiated using a sin-
gle dose of 2.5 nM of TPA to the dorsal ear skin and the skin was analysed 24 hr later.
Chemotaxis
Bone-marrow-derived basophils were FACS-sorted as CD45+cKit–FceRI+ cells at day 14 of culture
and 2  105 basophils placed in transwells with a pore size of 5 mm. 100 ng CXCL12 (Peprotech),
100 ng IL-3 (Peprotech) + 1 mg TSLP (R and D), C5a (as positive control) or media alone (negative
control) was placed in the bottom chamber and numbers of basophils migrating through the trans-
well at 37oC was enumerated after 4 hr.
Statistical evaluation
The statistical significance of difference between experimental groups was determined using two-
tailed Student’s t-test for unpaired data, one-way ANOVA multiple comparison, Log-rank Mantel-
Cox test or linear regression, where appropriate, with results deemed significant at p<0.05. Stars of
significance correlate to: *p<0.05; **p<0.01; ***p<0.001 and ****p<0.0001. Statistics were per-
formed with GraphPad Prism 6.00 for Mac (GraphPad; La Jolla, CA, USA).
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